Financial results - FOUR SEASONS PHARM SRL

Financial Summary - Four Seasons Pharm Srl
Unique identification code: 30785002
Registration number: J35/2519/2012
Nace: 4773
Sales - Ron
-
Net Profit - Ron
-3.874
Employees
1
Open Account
Company Four Seasons Pharm Srl with Fiscal Code 30785002 recorded a turnover of 2023 of - , with a net profit of -3.874 and having an average number of employees of 1. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Four Seasons Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 21.196 22.394 24.007 23.992 263.163 0 0 0 0 -
Total Income - EUR 21.207 22.394 24.007 23.992 263.486 8.024 0 2.483 1.427 -
Total Expenses - EUR 6.379 3.568 3.113 3.446 15.255 16.690 22.102 15.485 5.308 -
Gross Profit/Loss - EUR 14.827 18.826 20.894 20.546 248.232 -8.666 -22.102 -13.002 -3.881 -
Net Profit/Loss - EUR 14.191 18.154 20.174 19.826 245.357 -8.746 -22.102 -13.026 -3.895 -
Employees 0 0 0 0 1 1 1 1 1 -
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Four Seasons Pharm Srl

Rating financiar

Financial Rating -
FOUR SEASONS PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Four Seasons Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Four Seasons Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Four Seasons Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Four Seasons Pharm Srl - CUI 30785002

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 481 779 1.014 1.734 1.706 925 208 0 456 -
Current Assets 20.642 38.783 58.361 77.143 249.985 170.327 134.921 114.111 5.574 -
Inventories 0 0 1.442 1.416 1.388 1.362 1.332 1.336 1.332 -
Receivables 2.527 2.678 2.719 2.784 21.653 646 730 1.504 1.575 -
Cash 18.115 36.104 54.200 72.943 226.944 168.318 132.859 111.270 2.668 -
Shareholders Funds 19.274 37.232 56.776 75.560 245.407 169.729 133.755 113.033 -3.847 -
Social Capital 45 45 44 43 42 41 40 41 40 -
Debts 1.849 2.330 2.599 3.317 6.284 1.523 1.374 1.078 9.877 -
Income in Advance 0 0 0 0 0 0 0 0 0 -
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 5.574 euro in 2023 which includes Inventories of 1.332 euro, Receivables of 1.575 euro and cash availability of 2.668 euro.
The company's Equity was valued at -3.847 euro, while total Liabilities amounted to 9.877 euro. Equity decreased by -116.537 euro, from 113.033 euro in 2022, to -3.847 in 2023.

Risk Reports Prices

Reviews - Four Seasons Pharm Srl

Comments - Four Seasons Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.